Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Athira Pharma Inc

ATHA
Current price
0.24 USD +0.0027 USD (+1.14%)
Last closed 0.25 USD
ISIN US04746L1044
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 9 331 133 USD
Yield for 12 month -88.56 %
1Y
3Y
5Y
10Y
15Y
ATHA
21.11.2021 - 28.11.2021

Athira Pharma, Inc., clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. Its product pipeline includes ATH-1105 for the treatment of amyotrophic lateral sclerosis, which is in phase 1 clinical trial; ATH-1020 for the treatment of neurodegenerative diseases, which is phase 1 clinical trial, as well as early compounds which is in preclinical phase. The company was formerly known as M3 Biotechnology, Inc. and changed its name to Athira Pharma, Inc. in April 2019. Athira Pharma, Inc. was incorporated in 2011 and is headquartered in Bothell, Washington. Address: 18706 North Creek Parkway, Bothell, WA, United States, 98011

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

0.55 USD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

Last Year

-969 000 USD

Current Quarter

Last Quarter

Key Figures ATHA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -95 805 000 USD
Operating Margin TTM
Price to Earnings
Return On Assets TTM -55.23 %
PEG Ratio
Return On Equity TTM -110.77 %
Wall Street Target Price 0.55 USD
Revenue TTM
Book Value 1.15 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -2.52 USD
Diluted Eps TTM -2.52 USD
Most Recent Quarter IV 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics ATHA

Max Ratio

>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Dividend History ATHA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
Dividend CAGR 3Y
Dividend CAGR 5Y
Dividend CAGR 10Y
Consecutive Years
Consistent Years
Continuous Dividends
Forward Annual Dividend Yield
Forward Annual Dividend – USD
Last Split Factor
Payout Ratio
Last Split Date

Stock Valuation ATHA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA 1.31
Price Book MRQ 0.21

Financials ATHA

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators ATHA

For 52 weeks

0.22 USD 3.67 USD
50 Day MA 0.35 USD
Shares Short Prior Month 1 040 971
200 Day MA 1.07 USD
Short Ratio 4.58
Shares Short 934 467
Short Percent 3.38 %